ADVT Stock Overview
Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Advantis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.00% |
| 3 Year Change | -99.91% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ADVT | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 1.0% |
| 1Y | -99.0% | 10.6% | 21.9% |
Return vs Industry: ADVT underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: ADVT underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| ADVT volatility | |
|---|---|
| ADVT Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ADVT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ADVT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Darren Cherry | www.advantiscorp.com |
Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd.
Advantis Corp. Fundamentals Summary
| ADVT fundamental statistics | |
|---|---|
| Market cap | US$878.00 |
| Earnings (TTM) | -US$294.93k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs ADVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADVT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$294.93k |
| Earnings | -US$294.93k |
Last Reported Earnings
Dec 31, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ADVT perform over the long term?
See historical performance and comparison